Oracle To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Friday
Portfolio Pulse from Avi Kapoor
Top Wall Street analysts have updated their price targets and ratings for several companies, including Oracle, Moderna, and Garmin. Notably, Guggenheim raised Oracle's price target, while Barclays significantly cut Garmin's target.
September 13, 2024 | 3:54 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Barclays slashed Garmin's price target from $181 to $133, downgrading from Equal-Weight to Underweight. Garmin shares fell 6.2% to $170.74.
Barclays' significant cut in Garmin's price target and downgrade to Underweight suggests a negative outlook. The sharp decline in share price indicates strong market reaction.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
TD Cowen cut Moderna's price target from $70 to $60, maintaining a Hold rating. Moderna shares fell 4.9% to $66.25.
The reduction in Moderna's price target by TD Cowen, along with a Hold rating, indicates a cautious outlook. The significant drop in share price reflects investor concern.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
Guggenheim raised Oracle's price target from $185 to $200, maintaining a Buy rating. Oracle shares rose 1% to $162.87.
The increase in Oracle's price target by Guggenheim, along with a maintained Buy rating, suggests positive sentiment and potential for price appreciation. The 1% rise in shares reflects market optimism.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90